Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Berkshire Hathaway Finance Corp. 1.500% Senior Notes due 2030 BRK.30

Alternate Symbol(s):  BRK.A | BRK.B | BRK.25 | BRK.24 | BRK.28 | BRK.41 | N.BRK | BRK.34


The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NYSE:BRK.30)

Fundamentals Snapshot (NYSE:BRK.30)

Bullboard Posts (NYSE:BRK.30)

Air Electrode Battery Market Trends, Demand & Share 2021-26

According to IMARC Group’s latest report, titled “Air Electrode Battery Market: Global Industry Trends, Share, Size, Growth...
edwardebreen15 - September 1, 2022

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
EfraineJar - July 15, 2022

Berkshire having some real ugly volume bars.

Berkshire Hathaway Inc. (BRK-A) NYSE - Nasdaq Real Time Price. Currency in USD Add to...
CommonCentsforDollars - June 16, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >> FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets...
EfraineJar - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
EfraineJar - June 1, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
EfraineJar - May 10, 2022